Serum vascular endothelial growth factor‑C levels predict lymph node metastasis and prognosis of patients with gallbladder cancer

Jiang,Lei; Liu,Minchao; Cai,Xinran; Xie,Lijun; She,Feifei; Chen,Yanling

doi:10.3892/ol.2018.9358

Serum vascular endothelial growth factor‑C levels predict lymph node metastasis and prognosis of patients with gallbladder cancer

Authors:
- Lei Jiang
- Minchao Liu
- Xinran Cai
- Lijun Xie
- Feifei She
- Yanling Chen
View Affiliations

Affiliations: Department of Hepatobiliary Surgery, Union Clinical Medical College, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China, Department of Ultrasonic Image, The First Clinical Medical College, Fujian Medical University, Fuzhou, Fujian 350005, P.R. China, Key Laboratory of The Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China
Published online on: August 23, 2018 https://doi.org/10.3892/ol.2018.9358
Pages: 6065-6070

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lymph node metastasis is the primary site of metastasis for patients with gallbladder cancer (GBC). Vascular endothelial growth factor‑C (VEGF‑C) has been implicated in the control of lymphangiogenesis and lymph node metastasis in various malignant tumors. However, the function of circulating VEGF‑C is unclear and it is often difficult to evaluate lymph node metastasis and provide a prognosis for GBC. In the present study, ELISA was used to measure the preoperative serum VEGF‑C (sVEGF‑C) levels of 51 patients with GBC, 15 patients with chronic cholecystitis and 10 healthy volunteers. The results revealed a significantly increased sVEGF‑C level in patients with GBC compared with the healthy donors, however no statistically significant difference was identified between patients with GBC and chronic cholecystitis. sVEGF‑C levels were associated with lymph node metastasis in GBC and presented a positive correlation with VEGF‑C expression and lymphatic vessel density (LVD) in patients with GBC. The mean survival time with high sVEGF‑C was significantly reduced compared with low sVEGF‑C. A similar result was also observed for VEGF‑C expression and LVD. In summary, sVEGF‑C levels may predict lymph node metastasis and the prognosis of patients with GBC.

View Figures

View References

1	Muratore A, Polastri R and Capussotti L: Radical surgery for gallbladder cancer: Current options. Eur J Surg Oncol. 26:438–443. 2000. View Article : Google Scholar : PubMed/NCBI
2	Schoppmann SF, Fenzl A, Nagy K, Unger S, Bayer G, Geleff S, Gnant M, Horvat R, Jakesz R and Birner P: VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: Impact on lymphangiogenesis and survival. Surgery. 139:839–846. 2006. View Article : Google Scholar : PubMed/NCBI
3	Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K and Härkönen PL: VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer. 98:946–951. 2002. View Article : Google Scholar : PubMed/NCBI
4	Tanaka T, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Katada T, Shiozaki M, Naganawa Y, Fujii Y and Takeyama H: Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis. J Exp Clin Cancer Res. 29:832010. View Article : Google Scholar : PubMed/NCBI
5	Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Ylä-Herttuala S, Jäättelä M and Alitalo K: Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61:1786–1790. 2001.PubMed/NCBI
6	Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K, Matsutani N, Yasui W and Chayama K: Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer. 93:662–666. 2001. View Article : Google Scholar : PubMed/NCBI
7	Jiang L, Chen YL, She FF, Tang NH, Li XJ and Wang XX: Expressions of VEGF-C and VEGF-D and their correlation with lymphangiogenesis and angiogenesis in gallbladder carcinoma. Zhonghua Zhong Liu Za Zhi. 32:190–195. 2010.(In Chinese). PubMed/NCBI
8	Edge SB and Compton CC: The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI
9	Chen Y, Jiang L, She F, Tang N, Wang X, Li X, Han S and Zhu J: Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism. Mol Cell Biochem. 345:77–89. 2010. View Article : Google Scholar : PubMed/NCBI
10	Takanami I: Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer. Oncol Rep. 15:437–442. 2006.PubMed/NCBI
11	Varshney S, Butturini G and Gupta R: Incidental carcinoma of the gallbladder. Eur J Surg Oncol. 28:4–10. 2002. View Article : Google Scholar : PubMed/NCBI
12	Lazcano-Ponce EC, Miquel JF, Muñoz N, Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi Urista G and Nervi F: Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 51:349–364. 2001. View Article : Google Scholar : PubMed/NCBI
13	Shimada H, Endo I, Togo S, Nakano A, Izumi T and Nakagawara G: The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer. 79:892–899. 1997. View Article : Google Scholar : PubMed/NCBI
14	Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N and Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:290–298. 1996. View Article : Google Scholar : PubMed/NCBI
15	Ito Y, Shibata MA, Eid N, Morimoto J and Otsuki Y: Lymphangiogenesis and axillary lymph node metastases correlated with VEGF-C expression in two immunocompetent mouse mammary carcinoma models. Int J Breast Cancer. 2011:8671522011. View Article : Google Scholar : PubMed/NCBI
16	Maula SM, Luukkaa M, Grénman R, Jackson D, Jalkanen S and Ristamäki R: Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res. 63:1920–1926. 2003.PubMed/NCBI
17	Oh SJ, Jeltsch MM, Birkenhäger R, McCarthy JE, Weich HA, Christ B, Alitalo K and Wilting J: VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol. 188:96–109. 1997. View Article : Google Scholar : PubMed/NCBI
18	Tamura M and Ohta Y: Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: A possible diagnostic tool for lymph node metastasis. Cancer. 98:1217–1222. 2003. View Article : Google Scholar : PubMed/NCBI
19	Kozlowski M, Kowalczuk O, Milewski R, Chyczewski L, Niklinski J and Laudański J: Serum vascular endothelial growth factors C and D in patients with oesophageal cancer. Eur J Cardiothorac Surg. 38:260–267. 2010. View Article : Google Scholar : PubMed/NCBI
20	Xu T and Chen D: Serum vascular endothelial growth factor-C and vascular endothelial growth factor level in patients with colorectal carcinoma and clinical significance. J Huazhong Univ Sci Technolog Med Sci. 26:329–331. 2006. View Article : Google Scholar : PubMed/NCBI
21	Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, Jeltsch M, Petrova TV, Pytowski B, Stacker SA, et al: Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest. 115:247–257. 2005. View Article : Google Scholar : PubMed/NCBI
22	Mathur SP, Mathur RS, Gray EA, Lane D, Underwood PG, Kohler M and Creasman WT: Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. Gynecol Oncol. 98:467–483. 2005. View Article : Google Scholar : PubMed/NCBI
23	Gisterek I, Matkowski R, Lacko A, Sedlaczek P, Szewczyk K, Biecek P, Halon A, Staszek U, Szelachowska J, Pudelko M, et al: Serum vascular endothelial growth factors a, C and d in human breast tumors. Pathol Oncol Res. 16:337–344. 2010. View Article : Google Scholar : PubMed/NCBI
24	Wang TB, Deng MH, Qiu WS and Dong WG: Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer. World J Gastroenterol. 13:1794–1798. 2007. View Article : Google Scholar : PubMed/NCBI